Part of the book: Management of CNS Tumors
Part of the book: Evolution of the Molecular Biology of Brain Tumors and the Therapeutic Implications
Part of the book: Tumors of the Central Nervous System
Part of the book: Molecular Considerations and Evolving Surgical Management Issues in the Treatment of Patients with a Brain Tumor
Oligoastrocytoma (OA) was a glioma recognized in the current World Health Organization (WHO) classification of the central nervous system (CNS) tumors as a mixed tumor with an astrocytic and an oligodendroglial component. Its definability was, however, poor so that its prevalence varies in the various collections. A series of contributions of the literature and the “International Society of Neuropathology (ISN) – Haarlem Consensus” recently denied its existence as a tumor entity on the basis of 1p/19q, isocitrate dehydrogenase (IDH) and α-thalassemia/mental retardation syndrome X-linked (ATRX) status. Most tumors previously diagnosed as OAs were, therefore, reclassified as either oligodendrogliomas or astrocytomas.
Part of the book: Neurooncology